Bioalliance Pharma News
Most Popular Bioalliance Pharma Story
SpePharm demands $46.4M from BioAlliance Pharma
Amsterdam-based SpePharm Holding has filed a €35 million claim against BioAlliance Pharma for the "brutal termination" of a licensing agreement for the commercialization of the antifungal drug Read more...
Latest Headlines
- April 14, 2009
- July 16, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
